Clinical Trial Update: Neuropsyquiatric Evolution After Introduction of Raltegravir QD in Substitution of Dolutegravir: NEAR QD Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating neuropsychiatric outcomes after substituting dolutegravir with raltegravir in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)
• Tivicay (dolutegravir)

Snippet

Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Conditions: HIV Infections | Phase 4 | Status: UNKNOWN